Jin Lin, Kapadia Trupti Y, Von Gehr Ann, Rosas Efren, Bird James B, Ramaswamy Deepa, Patel Divyesh
Kaiser Permanente San Jose Medical Center, CA.
Perm J. 2019;23. doi: 10.7812/TPP/17-200.
Optimizing preoperative anemia is a required component of the Joint Commission Patient Blood Management Certification and an important component of Enhanced Recovery After Surgery.
To describe a preoperative anemia protocol developed and implemented at the Kaiser Permanente San Jose Medical Center in California to facilitate preoperative identification and treatment of anemia.
The protocol included all operations at risk of causing substantial blood loss. It excluded emergent operations and those for which the patient had a normal last hemoglobin value within the prior 12 months unless newly developed anemia was suspected. Eligible patients were screened for laboratory evaluation, and those with anemia were treated for reversible causes. Consistency was ensured by physician, staff, and patient education, and by use of electronic health records. Administration of intravenous iron and erythropoietin and consultation with specialists were expedited as part of a management algorithm.
Among 510 patients enrolled during 1 year, 442 (87%) received anemia screening laboratory tests. Half of those with laboratory results were eligible for further optimization: 207 had anemia and 21 had iron deficiency without anemia. Among the 228 patients eligible for optimization, 189 (83%) had anemia addressed preoperatively. Of 129 patients with iron deficiency anemia, 102 (79%) received intravenous iron preoperatively, with a mean preoperative increase in hemoglobin level by 0.98 g/dL (n = 79).
Integration of specialty services, optimization of technology, and consistency across practitioners were crucial for successful implementation and sustainability of a preoperative anemia protocol developed to expedite and enhance best practices.
优化术前贫血状况是联合委员会患者血液管理认证的必要组成部分,也是术后加速康复的重要组成部分。
描述加利福尼亚州凯撒永久医疗集团圣何塞医疗中心制定并实施的术前贫血方案,以促进术前贫血的识别和治疗。
该方案涵盖所有有大量失血风险的手术。排除急诊手术以及患者在过去12个月内血红蛋白值正常的手术,除非怀疑有新出现的贫血。对符合条件的患者进行实验室评估筛查,对贫血患者针对可逆病因进行治疗。通过医生、工作人员和患者教育以及使用电子健康记录来确保一致性。作为管理算法的一部分,加快静脉注射铁剂和促红细胞生成素的给药以及与专科医生的会诊。
在1年中纳入的510例患者中,442例(87%)接受了贫血筛查实验室检查。实验室检查结果符合进一步优化条件的患者占一半:207例有贫血,21例有缺铁但无贫血。在228例符合优化条件的患者中,189例(83%)在术前解决了贫血问题。在129例缺铁性贫血患者中,102例(79%)术前接受了静脉注射铁剂,术前血红蛋白水平平均升高0.98g/dL(n = 79)。
专科服务的整合、技术的优化以及从业者之间的一致性对于成功实施和维持为加快和加强最佳实践而制定的术前贫血方案至关重要。